This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by van der Vring, J.A.F.M. Articles by Hendriks, M.G.C. Search for Related Content PubMed PubMed Citation Articles by van der Vring, J.A.F.M. Articles by Hendriks, M.G.C. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB AMLODIPINE BESYLATE DILTIAZEM Medline Plus Health Information Angina Social Bookmarking                         What's this?

Combination of Calcium Channel Blockers and Beta Blockers for Patients with Exercise-Induced Angina Pectoris: A Double-Blind Parallel-Group Comparison of Different Classes of Calcium Channel Blockers

Department of Medicine, Merwede Hospital Dordrecht, Academic Hospital, Dordrecht, the Netherlands.

M.C.G. Daniëls, MD

Department of Medicine, Merwede Hospital Dordrecht, Academic Hospital, Dordrecht, the Netherlands.

N.J.H. Holwerda, MD

Department of Medicine, Merwede Hospital Dordrecht, Academic Hospital, Dordrecht, the Netherlands.

P.J.A.M. Withagen, MD

Department of Medicine, Merwede Hospital Dordrecht, Academic Hospital, Dordrecht, the Netherlands.

A. Schelling, MD

Department of Medicine, Merwede Hospital Dordrecht, Academic Hospital, Dordrecht, the Netherlands.

T.J. Cleophas, MD, PhD, FACA

Department of Medicine, Merwede Hospital Dordrecht, Academic Hospital, Dordrecht, the Netherlands.

M.G.C. Hendriks, MD, PhD

Department of Medicine, Merwede Hospital Dordrecht, Academic Hospital, Dordrecht, the Netherlands.

The combination of calcium channel blockers and beta blockers is more effective for the treatment of exercise-induced angina pectoris than beta blocker monotherapy. Since ischemia in exercise-induced angina is essentially preceded by an increase in heart rate, calcium channel blockers with negative chronotropic property may perform better for this purpose than nonchronotropic compounds. A 335-patient, 10-week, double-blind, parallel-group comparison of amlodipine 5 and 10 mg, diltiazem XR 200 and 300 mg, and mibefradil 50 and 100 mg treatment added to baseline beta blocker treatment was performed. Exercise testing (ETT) was performed by bicycle ergometry.

Although none of the calcium channel blockers improved duration of exercise or amount of workload, all of them significantly delayed onset of 1 mm ST segment depres sion on ETT (p<0.001 for any treatment versus baseline). In addition, mibefradil, both low- and high-dose treatment, produced the largest delays (low dose: different from diltiazem and amlodipine by 24.1 and 29.8 s, p<0.003 and <0.001, respectively; high (continued on next page) dose: different from diltiazem and amlodipine by 33.7 and 37.0 s, p<0.001 and <0.001, respectively). These effects were linearly correlated to the amount of rate pressure product (RPP) reduction. Serious symptoms of dizziness likewise occurred significantly more frequently with mibefradil (p<0.05) and led 19 patients taking mibefradil to withdraw from the trial.

The authors conclude that calcium channel blockers with negative chronotropic property provide better delay of ischemia in patients with exercise-induced angina but that the concomitant risk of intolerable dizziness largely reduces this benefit.

Angiology, Vol. 50, No. 6, 447-454 (1999)
DOI: 10.1177/000331979905000602


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?